Influence of a positive family history of both type 2 diabetes and PCOS on metabolic and endocrine parameters in a large cohort of PCOS women

被引:38
作者
Lerchbaum, Elisabeth [1 ,2 ]
Schwetz, Verena [1 ]
Giuliani, Albrecht [3 ]
Obermayer-Pietsch, Barbara [1 ]
机构
[1] Med Univ Graz, Dept Internal Med, Div Endocrinol & Metab, A-8036 Graz, Austria
[2] Univ Womens Hosp, D-69120 Heidelberg, Germany
[3] Med Univ Graz, Dept Obstet & Gynecol, A-8036 Graz, Austria
关键词
POLYCYSTIC-OVARY-SYNDROME; IMPAIRED GLUCOSE-TOLERANCE; LIPID-ACCUMULATION PRODUCT; INSULIN-RESISTANCE; PREVALENCE; RISK; SENSITIVITY; DIAGNOSIS; PREDICTORS; MELLITUS;
D O I
10.1530/EJE-13-1035
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objective: There is evidence suggesting a strong genetic background of polycystic ovary syndrome (PCOS). We aim to study the metabolic and endocrine characteristics of PCOS women with and without a family history (FHx) of type 2 diabetes mellitus (T2DM) and PCOS. Design: Cross-sectional study. Methods: We analysed the association of T2DM FHx and PCOS FHx with metabolic and endocrine parameters in 714 PCOS women. Results: A positive FHx of T2DM and PCOS were prevalent in 36.8 and 21.4% of PCOS women respectively. We found an independent association of T2DM FHx with central fat accumulation, obesity, prediabetes, metabolic syndrome (MS), insulin resistance, low HDL and elevated blood pressure (P < 0.05 for all). PCOS FHx was independently associated with prediabetes (P < 0.05). We observed an independent association of PCOS FHx with clinical and biochemical hyperandrogenism (P < 0.05 for all), whereas there was no independent association of T2DM FHx with hyperandrogenism. PCOS women with a positive FHx of both T2DM and PCOS had an adverse metabolic and endocrine profile including a linear increase in risk of obesity, central fat accumulation, MS, prediabetes and low HDL (P < 0.05 for all). Conclusions: Our findings suggest that the assessment of FHx might allow risk stratification of PCOS women, which is important considering the high prevalence of PCOS.
引用
收藏
页码:727 / 739
页数:13
相关论文
共 40 条
[1]
Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test [J].
Abdul-Ghani, Muhammad A. ;
Matsuda, Masafumi ;
Balas, Bogdan ;
DeFronzo, Ralph A. .
DIABETES CARE, 2007, 30 (01) :89-94
[2]
Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women [J].
Alvarez-Blasco, Francisco ;
Botella-Carretero, Jose I. ;
San Millan, Jose L. ;
Escobar-Morreale, Hector F. .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (19) :2081-2086
[3]
Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment [J].
Amato, M. C. ;
Guarnotta, V. ;
Forti, D. ;
Donatelli, M. ;
Dolcimascolo, S. ;
Giordano, C. .
HUMAN REPRODUCTION, 2013, 28 (07) :1919-1928
[4]
Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc10-S062, 10.2337/dc14-S081, 10.2337/dc11-S011, 10.2337/dc13-S011, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062, 10.2337/dc10-S011, 10.2337/dc12-s011]
[5]
Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198
[6]
Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS [J].
Carmina, E ;
Napoli, N ;
Longo, RA ;
Rini, GB ;
Lobo, RA .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 154 (01) :141-145
[7]
Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters [J].
Carmina, E ;
Chu, MC ;
Longo, RA ;
Rini, GB ;
Lobo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (05) :2545-2549
[8]
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications [J].
Diamanti-Kandarakis, Evanthia ;
Dunaif, Andrea .
ENDOCRINE REVIEWS, 2012, 33 (06) :981-1030
[9]
Medical progress: Polycystic ovary syndrome [J].
Ehrmann, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (12) :1223-1236
[10]
Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome [J].
Ehrmann, DA ;
Liljenquist, DR ;
Kasza, K ;
Azziz, R ;
Legro, RS ;
Ghazzi, MN .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01) :48-53